Article ID: 694781 Mayo ClinicUn fármaco utilizado en el cáncer sanguíneo puede resultar útil en el cáncer de mama triple negativo, descubrieron los investigadores de Mayo Clinic. El cáncer de mama triple negativo es uno de los tipos más agresivos y letales de cáncer de mama. El estudio se publicó en la Revista de Investigación Clínica. |
Article ID: 649790 Inside Cancer Cells, Tumor Growth in Kidney Cancer, Genetic Screening Guidelines, and More in the Cancer News SourceNewswiseClick here to go directly to the Cancer News Source Channels: Biotech, Blood Disorders, Bone Health, Cancer, Cell Biology, Chemistry, Children's Health, Complementary Medicine, Dermatology, Genetics, Healthcare, Immunology, Drug Resistance, Infectious Diseases, Kidney Disease, Men's Health, Mental Health, Military Health, Mindfulness, Neuro, Nursing, Nutrition, OBGYN, Oral Health, Pain, Personalized Medicine, Pharmaceuticals, |
|
Article ID: 694156 National Institute of Biomedical Imaging and BioengineeringBioengineers have developed micro-technologies that capture extracellular vesicles (EVs) released by brain tumors. The vesicles carry samples of the mutated genetic material and proteins causing malignancy that researchers can analyze to optimize precision cancer treatment. |
|
Article ID: 693960 Health Sciences at the University of PittsburghOn May 6, the National Institutes of Health will open national enrollment for the All of Us Research Program in collaboration the University of Pittsburgh and other partners. |
|
Article ID: 693861 Mayo Clinic明尼苏达州罗切斯特 – 5月6日美国国立卫生研究院将开放 “我们所有人”研究计划的全国注册。 根据国立卫生研究院的资讯，这项计划旨在推动具有各种不同背景的所有人的个人化预防，治疗和护理。 |
|
Article ID: 693828 Mayo ClinicEl 6 de mayo próximo, los Institutos Nacionales de Salud (NIH, por sus siglas en inglés) abrirán las inscripciones en todo el país para el programa de investigación “Todos nosotros”. |
|
Article ID: 693817 Mayo ClinicOn May 6, the National Institutes of Health (NIH) will open national enrollment for the All of Us Research Program. According to the NIH the program is a momentous effort to advance individualized prevention, treatment and care for people of all backgrounds. Channels: Healthcare, Personalized Medicine, Pharmaceuticals, Public Health All of Us, All of Us Research Program, All of Us Research Program biobank, Florida News Releases, Mayo Clinic, Mayo Clinic Center for Individualized Medicine, Medical Research, Minnesota News Releases, news releases, Precision Medicine |
|
Article ID: 693797 University of California San Diego HealthThe All of Us Research Program officially opens for enrollment Sunday, May 6. Led by the National Institutes of Health (NIH), All of Us is an unprecedented effort to gather genetic, biological, environmental, health and lifestyle data from 1 million or more volunteer participants living in the United States. A major component of the federal Precision Medicine Initiative, the program’s ultimate goal is to accelerate research and improve health. Channels: Genetics, Healthcare, Personalized Medicine, Public Health, Local - California Genetics, genes, Cancer, Clinical Trials, Epidemiology, Health Professionals, Public Health, Internal Medicine, Behavior, Demography, Precision Medicine, Personalized Medicine, Pharmacogenomics, All of Us Research, All of Us, NIH |
Article ID: 693613 Dana-Farber Cancer InstituteThe majority of patients with diffuse large B cell lymphoma (DLBCL) can be treated effectively. However, people whose disease recurs face a shortage of good options, especially because the disease is driven by a complicated mix of genetic alterations. Genomic analysis by scientists at Dana-Farber Cancer Institute and the Broad Institute of MIT and Harvard now offers a better framework for understanding the disease’s many forms, which will help to predict individual patient outcomes and guide personalized treatment. |
Article ID: 693499 Washington University in St. LouisTaking a biopsy of a brain tumor is a complicated and invasive surgical process, but a team of researchers at Washington University in St. Louis is developing a way that allows them to detect tumor biomarkers through a simple blood test. |